Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$66.18 - $83.18 $210,981 - $265,177
-3,188 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$66.02 - $79.71 $63,181 - $76,282
-957 Reduced 23.09%
3,188 $253,000
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $95,010 - $111,165
-1,500 Reduced 26.57%
4,145 $305,000
Q3 2021

Nov 12, 2021

SELL
$68.67 - $84.02 $15,931 - $19,492
-232 Reduced 3.95%
5,645 $389,000
Q2 2021

Aug 10, 2021

SELL
$79.87 - $87.53 $63,896 - $70,024
-800 Reduced 11.98%
5,877 $494,000
Q1 2021

May 10, 2021

BUY
$76.02 - $100.5 $18,320 - $24,220
241 Added 3.74%
6,677 $542,000
Q4 2020

Feb 11, 2021

BUY
$80.74 - $97.7 $39,885 - $48,263
494 Added 8.31%
6,436 $560,000
Q2 2020

Aug 17, 2020

BUY
$74.18 - $108.93 $70,322 - $103,265
948 Added 18.98%
5,942 $617,000
Q1 2020

May 11, 2020

BUY
$63.18 - $85.97 $17,690 - $24,071
280 Added 5.94%
4,994 $365,000
Q4 2019

Feb 04, 2020

SELL
$73.04 - $95.72 $41,340 - $54,177
-566 Reduced 10.72%
4,714 $344,000
Q3 2019

Nov 07, 2019

BUY
$72.82 - $86.52 $24,758 - $29,416
340 Added 6.88%
5,280 $443,000
Q2 2019

Aug 12, 2019

SELL
$73.52 - $88.7 $1.05 Million - $1.26 Million
-14,260 Reduced 74.27%
4,940 $420,000
Q1 2019

May 10, 2019

BUY
$63.56 - $88.17 $890,729 - $1.24 Million
14,014 Added 270.23%
19,200 $1.65 Million
Q4 2018

Feb 06, 2019

BUY
$58.5 - $69.94 $2,866 - $3,427
49 Added 0.95%
5,186 $330,000
Q3 2018

Nov 13, 2018

SELL
$61.75 - $74.23 $30,875 - $37,115
-500 Reduced 8.87%
5,137 $333,000
Q2 2018

Aug 14, 2018

SELL
$60.85 - $83.98 $51,296 - $70,795
-843 Reduced 13.01%
5,637 $378,000
Q1 2018

May 09, 2018

SELL
$83.06 - $100.98 $8,970 - $10,905
-108 Reduced 1.64%
6,480 $539,000
Q4 2017

Jan 26, 2018

BUY
$93.56 - $116.6 $561 - $699
6 Added 0.09%
6,588 $624,000
Q3 2017

Oct 11, 2017

BUY
$109.15 - $138.27 $718,425 - $910,093
6,582
6,582 $769,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cigna Investments Inc Portfolio

Follow Cigna Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Cigna Investments Inc with notifications on news.